Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EFFECTS OF THE RESTATEMENT TO AMOUNTS IN THE PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS (Details)

v3.23.3
SCHEDULE OF EFFECTS OF THE RESTATEMENT TO AMOUNTS IN THE PREVIOUSLY REPORTED CONSOLIDATED FINANCIAL STATEMENTS (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Change in fair value of warrant liabilities $ (1,101) $ 3,050 $ (7,465) $ 5,995        
Net loss (11,836) (6,434) (37,597) (32,575)        
Net loss attributable to Common Shareholders $ (11,836) $ (6,434) $ (37,597) $ (36,357)        
Loss per common share - basic $ (0.48) $ (1.00) $ (1.89) $ (6.05)        
Loss per common share - diluted $ (0.48) $ (1.00) $ (1.89) $ (6.05)        
Comprehensive loss $ (11,840) $ (6,444) $ (37,567) $ (36,374)        
Additional paid in capital 754,823 700,583 754,823 700,583   $ 722,049 $ 694,372 $ 696,563
Stockholders equity 22,038 12,401 22,038 12,401 $ 9,345 26,761 14,024 42,368
Accumulated deficit 732,933 (688,215) 732,933 (688,215)   $ 695,336 (681,781)  
Change in fair value of warrant liabilities $ 1,101 (3,050) 7,465 (5,995)        
Net cash used in operating activities     $ (27,774) (29,491)        
Previously Reported [Member]                
Change in fair value of warrant liabilities            
Net loss   (9,484)   (38,570)        
Net loss attributable to Common Shareholders   $ (9,484)   $ (42,352)        
Loss per common share - basic   $ (1.48)   $ (7.05)        
Loss per common share - diluted   $ (1.48)   $ (7.05)        
Comprehensive loss   $ (9,494)   $ (42,369)        
Additional paid in capital   709,590   709,590     703,379 705,570
Stockholders equity   15,413   15,413     20,086 51,375
Accumulated deficit   (694,210)   (694,210)     (684,726)  
Change in fair value of warrant liabilities            
Net cash used in operating activities       (29,491)        
Revision of Prior Period, Adjustment [Member]                
Change in fair value of warrant liabilities   3,050   5,995        
Net loss   3,050   5,995        
Net loss attributable to Common Shareholders   $ 3,050   $ 5,995        
Loss per common share - basic   $ 0.48   $ 1.00        
Loss per common share - diluted   $ 0.48   $ 1.00        
Comprehensive loss   $ 3,050   $ 5,995        
Additional paid in capital   (9,007)   (9,007)     (9,007) (9,007)
Stockholders equity   (3,012)   (3,012)     (6,062) $ (9,007)
Accumulated deficit   5,995   5,995     $ 2,945  
Change in fair value of warrant liabilities   $ (3,050)   (5,995)        
Net cash used in operating activities